Company Plicit Capital Corp Toronto S.E.
Equities
PLPh
CA7291431079
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
05-15 | Telo Genomics Corp. Signs Collaboration Agreement with Emery Pharma | CI |
04-10 | Telo Genomics Receives Accreditation from College of American Pathologists | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kris Weinberg
CEO | Chief Executive Officer | - | 22-12-11 |
Sherif Louis
PSD | President | - | 14-12-31 |
Christopher Ross
DFI | Director of Finance/CFO | - | 21-03-31 |
Hugh Rogers
BRD | Director/Board Member | 44 | 15-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Meekison
BRD | Director/Board Member | 58 | 18-06-30 |
Director/Board Member | - | 22-02-02 | |
Guido Baechler
CHM | Chairman | 59 | 19-02-27 |
Hugh Rogers
BRD | Director/Board Member | 44 | 15-03-31 |
Sabine Mai
FOU | Founder | - | 11-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 71,309,933 | 67,327,029 ( 94.41 %) | 0 | 94.41 % |
Company contact information
Telo Genomics Corp.
MaRS Centre, South Tower 101 College Street
M5G 1L7, Toronto
+416-673-8487
http://www.telodx.comSector
1st Jan change | Capi. | |
---|---|---|
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M |
- Stock Market
- Equities
- TELO Stock
- PLPh Stock
- Company Plicit Capital Corp